Literature DB >> 26915107

Effects of High Glucose on Cell Viability and Differentiation in Primary Cultured Schwann Cells: Potential Role of ERK Signaling Pathway.

Di Liu1, Xiaochun Liang2, Hong Zhang3.   

Abstract

Diabetic peripheral neuropathy (DPN) is one of the most common complications of diabetes mellitus and hyperglycemia is considered to be the major factor in the development and progression of DPN. Because of the contribution of Schwann cells (SCs) to the pathology of DPN, we investigated the effects of high glucose on cell proliferation, apoptosis and differentiation in primary cultured SCs. Cell Counting Kit-8 (CCK-8) assay and Hoechst staining showed that high glucose inhibited SCs proliferation and increased apoptosis ratio in time and concentration dependent manner. Western blot and real-time quantitative PCR analysis revealed that the major myelin proteins and genes expressions including P0, MAG and Krox-20, were downregulated time dependently in SCs exposed to high glucose from 48 to 96 h. To further elucidate the underlying pathogenic mechanisms, we also explored the role of ERK signaling pathway in high glucose induced SC injury, which has been proved to drive demyelination of peripheral nerves. The western blot analysis showed that compared with control group phosphorylation level of ERK was increased by 14.3 % in SCs exposed to high glucose for 72 h (P < 0.01). Using immunocytochemistry analysis, we observed that the ERK specific inhibitor U0126 blocked the ERK activation induced by high glucose and reversed the inhibitory effect of high glucose on P0 expression. Taken together, these results suggest that high glucose can cause damage in primary cultured SCs and may exert the inhibitory effect on SC differentiation and myelination through ERK signaling activation.

Entities:  

Keywords:  Diabetic peripheral neuropathy; Differentiation; ERK signaling pathway; High glucose; Schwann cells

Mesh:

Substances:

Year:  2016        PMID: 26915107     DOI: 10.1007/s11064-015-1824-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

1.  12/15-Lipoxygenase inhibition counteracts MAPK phosphorylation in mouse and cell culture models of diabetic peripheral neuropathy.

Authors:  Roman Stavniichuk; Alexander A Obrosov; Viktor R Drel; Jerry L Nadler; Irina G Obrosova; Mark A Yorek
Journal:  J Diabetes Mellitus       Date:  2013-08

2.  Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons.

Authors:  Indranil Dey; Nisha Midha; Geeta Singh; Amanda Forsyth; Sarah K Walsh; Bhagat Singh; Ranjan Kumar; Cory Toth; Rajiv Midha
Journal:  Glia       Date:  2013-10-07       Impact factor: 7.452

Review 3.  Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin.

Authors:  M Schachner; U Bartsch
Journal:  Glia       Date:  2000-01-15       Impact factor: 7.452

4.  Delayed Schwann cell and oligodendrocyte remyelination after ethidium bromide injection in the brainstem of Wistar rats submitted to streptozotocin diabetogenic treatment.

Authors:  E F Bondan; M A Lallo; A H Trigueiro; C P Ribeiro; I L Sinhorini; D L Graça
Journal:  Braz J Med Biol Res       Date:  2006-04-20       Impact factor: 2.590

5.  Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production.

Authors:  Liang Zhang; Cuijuan Yu; Francisco E Vasquez; Nadya Galeva; Isaac Onyango; Russell H Swerdlow; Rick T Dobrowsky
Journal:  J Proteome Res       Date:  2010-01       Impact factor: 4.466

6.  Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons.

Authors:  Takahiro Tosaki; Hideki Kamiya; Yutaka Yasuda; Keiko Naruse; Koichi Kato; Mika Kozakae; Nobuhisa Nakamura; Taiga Shibata; Yoji Hamada; Eitaro Nakashima; Yutaka Oiso; Jiro Nakamura
Journal:  Exp Neurol       Date:  2008-07-09       Impact factor: 5.330

7.  Hyperglycaemia inhibits Schwann cell proliferation and migration and restricts regeneration of axons and Schwann cells from adult murine DRG.

Authors:  Laura F Gumy; Edward T W Bampton; Aviva M Tolkovsky
Journal:  Mol Cell Neurosci       Date:  2007-10-18       Impact factor: 4.314

8.  Diminished Schwann cell repair responses underlie age-associated impaired axonal regeneration.

Authors:  Michio W Painter; Amanda Brosius Lutz; Yung-Chih Cheng; Alban Latremoliere; Kelly Duong; Christine M Miller; Sean Posada; Enrique J Cobos; Alice X Zhang; Amy J Wagers; Leif A Havton; Ben Barres; Takao Omura; Clifford J Woolf
Journal:  Neuron       Date:  2014-07-16       Impact factor: 17.173

9.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

10.  Relationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).

Authors:  Sabita S Soedamah-Muthu; Nish Chaturvedi; Daniel R Witte; Lynda K Stevens; Massimo Porta; John H Fuller
Journal:  Diabetes Care       Date:  2008-03-28       Impact factor: 19.112

View more
  7 in total

Review 1.  Schwann cell interactions with axons and microvessels in diabetic neuropathy.

Authors:  Nádia P Gonçalves; Christian B Vægter; Henning Andersen; Leif Østergaard; Nigel A Calcutt; Troels S Jensen
Journal:  Nat Rev Neurol       Date:  2017-01-30       Impact factor: 42.937

2.  Combining in silico and in vitro models to inform cell seeding strategies in tissue engineering.

Authors:  R Coy; G Al-Badri; C Kayal; C O'Rourke; P J Kingham; J B Phillips; R J Shipley
Journal:  J R Soc Interface       Date:  2020-03-25       Impact factor: 4.118

3.  A microfabricated multi-compartment device for neuron and Schwann cell differentiation.

Authors:  Eleonora De Vitis; Velia La Pesa; Francesca Gervaso; Alessandro Romano; Angelo Quattrini; Giuseppe Gigli; Lorenzo Moroni; Alessandro Polini
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

4.  Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia.

Authors:  Tianshu Gao; Jin Xu; Yuxiao Xiao; Jiaqi Li; Weifeng Hu; Xiaoyu Su; Xudong Shen; Wan Yu; Zhen Chen; Baosheng Huang; Honglei Li; Xing Wang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

5.  Schwann cells-derived exosomal miR-21 participates in high glucose regulation of neurite outgrowth.

Authors:  Yu-Pu Liu; Ming-Yue Tian; Yi-Duo Yang; Han Li; Tian-Tian Zhao; Jing Zhu; Fang-Fang Mou; Guo-Hong Cui; Hai-Dong Guo; Shui-Jin Shao
Journal:  iScience       Date:  2022-09-15

Review 6.  Peripheral Glial Cells in the Development of Diabetic Neuropathy.

Authors:  Nádia Pereira Gonçalves; Christian Bjerggaard Vægter; Lone Tjener Pallesen
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

7.  Regulatory Effects of Astragaloside IV on Hyperglycemia-Induced Mitophagy in Schwann Cells.

Authors:  Xiaoyi Wei; Yalin Zheng; Yanke Ai; Buman Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-11       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.